Does CRIZOTINIB Cause Neoplasm progression? 1,161 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,161 reports of Neoplasm progression have been filed in association with CRIZOTINIB (Xalkori). This represents 11.7% of all adverse event reports for CRIZOTINIB.
1,161
Reports of Neoplasm progression with CRIZOTINIB
11.7%
of all CRIZOTINIB reports
350
Deaths
222
Hospitalizations
How Dangerous Is Neoplasm progression From CRIZOTINIB?
Of the 1,161 reports, 350 (30.1%) resulted in death, 222 (19.1%) required hospitalization, and 12 (1.0%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRIZOTINIB. However, 1,161 reports have been filed with the FAERS database.
What Other Side Effects Does CRIZOTINIB Cause?
Death (2,028)
Nausea (820)
Disease progression (677)
Diarrhoea (631)
Vomiting (600)
Fatigue (419)
Off label use (353)
Dyspnoea (352)
Visual impairment (315)
Constipation (313)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
VINCRISTINE (1,106)
GEMCITABINE (960)
Which CRIZOTINIB Alternatives Have Lower Neoplasm progression Risk?
CRIZOTINIB vs CROFELEMER
CRIZOTINIB vs CROMOLYN
CRIZOTINIB vs CROTALIDAE POLYVALENT IMMUNE FAB
CRIZOTINIB vs CUBICIN
CRIZOTINIB vs CUPRIC